Long-term follow-up of mTOR inhibition for Erdheim-Chester disease

被引：19
作者：
Pegoraro, Francesco [1 ]
Maniscalco, Valerio [1 ]
Peyronel, Francesco [2 ]
Westenend, Pieter J. [3 ]
Hendriksz, Tadek R. [4 ]
Roperto, Rosa M. [5 ]
Palumbo, Alessandro A. [6 ]
Sieni, Elena [7 ]
Romagnani, Paola [5 ,8 ]
van Bommel, Eric F. H. [9 ]
Vaglio, Augusto [5 ,8 ]
机构：
[1] Univ Firenze, Dept Hlth Sci, Florence, Italy
[2] Univ Hosp, Nephrol Unit, Parma, Italy
[3] Albert Schweitzer Hosp, Dutch Natl Ctr Expertise Retroperitoneal Fibrosis, Dept Pathol, Dordrecht, Netherlands
[4] Albert Schweitzer Hosp, Dutch Natl Ctr Expertise Retroperitoneal Fibrosis, Dept Radiol, Dordrecht, Netherlands
[5] Meyer Childrens Hosp, Nephrol & Dialysis Unit, Florence, Italy
[6] Univ Hosp, Dept Radiol, Parma, Italy
[7] Meyer Childrens Hosp, Dept Pediat Hematol & Oncol, Florence, Italy
[8] Univ Firenze, Dept Biomed Expt & Clin Sci Mario Serio, Viale Pieraccini 6, I-50139 Florence, Italy
[9] Albert Schweitzer Hosp, Dept Nephrol, Dutch Natl Ctr Expertise Retroperitoneal Fibrosis, Dordrecht, Netherlands
来源：
BLOOD | 2020年 / 135卷 / 22期
关键词：
LANGERHANS CELL HISTIOCYTOSIS; VEMURAFENIB; NEOPLASMS; EFFICACY; CRITERIA; RECIST;
D O I：
10.1182/blood.2019004478
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1994 / 1997
页数：4
相关论文
共 50 条
  • [41] Neurological onset of Erdheim-Chester disease
    Cuello-Oderiz, Carolina
    Pigretti, Santiago
    Patrucco, Liliana
    REVISTA DE NEUROLOGIA, 2014, 59 (12) : 572 - 574
  • [42] ERDHEIM-CHESTER DISEASE: NEW ADVANCES
    Haddley, K.
    DRUGS OF THE FUTURE, 2011, 36 (05) : 403 - 408
  • [43] Clinical and positron emission tomography responses to long-term high-dose interferon- treatment among patients with Erdheim-Chester disease
    Cao, Xin-xin
    Niu, Na
    Sun, Jian
    Cai, Hao
    Wang, Feng-dan
    Wang, Yi-ning
    Duan, Ming-hui
    Zhou, Dao-bin
    Li, Jian
    ORPHANET JOURNAL OF RARE DISEASES, 2019, 14 (1)
  • [44] Recent advances in therapeutic strategies of Erdheim-Chester disease
    Doke, Rohit
    Lokhande, Rahul
    Chande, Kalyani
    Vinchurkar, Kuldeep
    Prajapati, Bhupendra G.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2025, : 6407 - 6428
  • [45] Paediatric Erdheim-Chester disease with aggressive skin manifestations
    Su, H. -H.
    Wu, W.
    Guo, Y.
    Chen, H. -D.
    Shan, S. -J.
    BRITISH JOURNAL OF DERMATOLOGY, 2018, 178 (01) : 261 - 264
  • [46] Langerhans cell histiocytosis and Erdheim-Chester disease, a continuity?
    Parreau, S.
    Haroche, J.
    Pommepuy, I.
    Emile, J. F.
    Bourras, J. C.
    Archambeaud, F.
    REVUE DE MEDECINE INTERNE, 2017, 38 (07): : 482 - 487
  • [47] Erdheim-Chester Disease: An Unusual Cause of Intracranial Vasculitis and Progressive Leukoencephalopathy
    Sagnier, Sharmila
    Debruxelles, Sabrina
    Lepreux, Sebastien
    Sibon, Igor
    JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2016, 25 (05) : E63 - E65
  • [48] Homonymous Hemianopia Due to Erdheim-Chester Disease
    Hills, William L.
    Nassef, Ahmad H.
    Grafe, Marjorie R.
    Weissman, Jane L.
    Moster, Stephen J.
    Falardeau, Julie
    Mardekian, Stacey K.
    Curtis, Mark T.
    Moster, Mark L.
    JOURNAL OF NEURO-OPHTHALMOLOGY, 2014, 34 (03) : 237 - 242
  • [49] Erdheim-Chester disease and vemurafenib: a review of ophthalmic presentations and clinical outcomes
    Park, Ji Kwan
    Huang, Laura C.
    Kossler, Andrea L.
    ORBIT-THE INTERNATIONAL JOURNAL ON ORBITAL DISORDERS-OCULOPLASTIC AND LACRIMAL SURGERY, 2023, 42 (03): : 233 - 244
  • [50] Langerhans cell histiocytosis and Erdheim-Chester disease
    Wilejto, Marta
    Abla, Oussama
    CURRENT OPINION IN RHEUMATOLOGY, 2012, 24 (01) : 90 - 96
12345